- Exchange: OTC US
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Drug Delivery Systems
Cipher Pharmaceuticals Inc
+ Add to WatchlistCPHMF:US
3.7652 USD 0.1752 4.88%As of 20:10:00 ET on 05/21/2013.
Snapshot for Cipher Pharmaceuticals Inc (CPHMF)
| Open: | 3.6900 | Day's Range: | 3.6900 - 3.7957 | Volume: | 4,500 |
|---|---|---|---|---|---|
| Previous Close: | 3.5900 | 52wk Range: | 1.3140 - 4.1010 | 1-Yr Rtn: | +177.20% |
Key Statistics for CPHMF
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | 12.8695 |
| Relative P/E vs. SPX | - |
| Earnings Per Share (CAD) (ttm) | - |
| Est. EPS (CAD) (12/2013) | 0.3000 |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 0.00 |
| Shares Outstanding (M) | 0.00 |
| 30 Day Average Volume | 3,487 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 07/25/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for CPHMF
Company Profile & Key Executives for CPHMF
Cipher Pharmaceuticals Inc. is involved in the licensing, clinical development, and regulatory approval of prescription medications utilizing drug delivery technologies or new pharmaceuticals. The Company also conducts clinical trials, regulatory affairs services, and statistical analysis for the pharmaceutical, biotechnology, and medical devices industries.
| William C GarriockChairman | Larry AndrewsPresident/CEO |
| Norman EvansCFO/Secretary | Jason GrossVP:Scientific Affairs |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
CPHMF News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page